Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The Brazilian national health surveillance agency, the Anvisa, has approved the biological control agent, Amblyseius tamatavensis, subject to a 60-day public comment period.
Dutch bioproducts company Koppert Biological Systems has received registration in France for its new yeast-based biofungicide, Noli (Metschnikowia fructicola).
The Brazilian Ministry of Agriculture has approved another batch of dozens of pesticide products including new biologicals.
The Brazilian national health surveillance agency, the Anvisa, approved three biological pesticide active ingredients.
A Brazilian federal judge has suspended the authorisations of 63 pesticide products.
Israeli plant biotechnology company Evogene's (Rehovot) agricultural biologicals subsidiary, Lavie Bio (Lavie), has achieved phase advancement in its product pipeline for wheat biostimulants.
US biopesticide company Marrone Bio Innovations (MBI – Davis, California) is developing a bioherbicide that has demonstrated control of Palmer amaranth (Amaranthus palmeri) approaching that of a post-emergence chemical herbicide, the company claims.
UPL's North American business, UPL NA, has received approval in the US state of California for the biopesticide, VacciPlant (laminarin), on grapevines and lettuces.
The US EPA has notified the receipt of applications to register two biopesticides based on new active ingredients.
The Canadian Pest Management Regulatory Agency (PMRA) has approved Dutch company Valto's viral pesticide, V10 (mild pepino mosaic virus strain LP, isolate VX1 + mild pepino mosaic virus strain CH2, isolate VC1).
Australian biopesticide company AgBiTech (Glenvale, Queensland), is to launch the world's first quadruple Baculovirus mixture in Brazil.
Brazilian biologicals business, Microquimica Tradecorp, has expanded its biologicals manufacturing facility in Monte Mor, Sao Paulo.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.